Endava (DAVA) revenue breakdown
By product, Banking and Capital Markets is the largest at 20% of fiscal 2025 revenue; Healthcare grew fastest, 78% a year over 2 years.
By region, North America is the largest at 38% of fiscal 2025 revenue; RoW grew fastest, 35% a year over 5 years.
Revenue by product
Fiscal years, as Endava reports them in its 10-K filings; fiscal 2025 total $772M.
| Products | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| Banking and Capital Markets | — | — | — | — | — | — | $129M | $111M | $152M | 20% |
| Technology, Media & Telecom | $49M | $61M | $79M | $90M | $121M | $164M | $174M | $169M | $147M | 19% |
| Payments | — | — | — | — | — | — | $232M | $179M | $145M | 19% |
| Other | $20M | $33M | $57M | $76M | $99M | $159M | $95M | $101M | $102M | 13% |
| Healthcare | — | — | — | — | — | — | $29M | $45M | $91M | 12% |
| Insurance | — | — | — | — | — | — | $55M | $62M | $70M | 9% |
| Mobility | — | — | — | — | — | — | $80M | $74M | $65M | 8% |
| Payments and Financial Services | $91M | $124M | $152M | $185M | $226M | $332M | — | — | — | — |
Revenue by region
Fiscal years, as Endava reports them in its 10-K filings; fiscal 2025 total $772M.
| Regions | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | $21M | $26M | $46M | $79M | $100M | $140M | $228M | $258M | $242M | $295M | 38% |
| United Kingdom | $74M | $80M | $99M | $130M | $156M | $187M | $271M | $309M | $248M | $254M | 33% |
| Europe | $20M | $53M | $73M | $79M | $86M | $108M | $138M | $183M | $191M | $181M | 23% |
| RoW | — | — | — | — | $9M | $11M | $18M | $45M | $60M | $42M | 5% |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for DAVA.
Open DAVA in InvestinglyQuestions
Where does Endava make its money?
In fiscal 2025, by product: Banking and Capital Markets $152M, Technology, Media & Telecom $147M, Payments $145M, Other $102M, Healthcare $91M.
From Endava's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.